[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343144-105":59,"doc-detail-343144-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","smart-delivery-vehicles-for-cancer-categories-unique-roles-and-therapeutic-strategies","Smart delivery vehicles for cancer: categories, unique roles and therapeutic strategies","","Cancer research and clinical practice continue to rely on chemotherapy and surgery, yet these modalities suffer from recurrence risks, drug resistance, and systemic toxicities caused by nonspecific distribution and limited bioaccessibility. This review synthesizes smart therapeutic carrier types and explains drug-delivery mechanisms, highlighting benefits for cancer treatment and particular relevance to cancer immunotherapy. It also addresses integration with emerging strategies, then reviews development bottlenecks and proposes directions for future research.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/smart-delivery-vehicles-for-cancer-categories-unique-roles-and-therapeutic-strategies/343144/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/smart-delivery-vehicles-for-cancer-categories-unique-roles-and-therapeutic-strategies/343144.png","ImageObject",300,407,{"name":92,"@type":93},"Theodore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are conventional chemotherapy and surgery insufficient for cancer treatment?","Question",{"text":112,"@type":113},"They can lead to recurrence and systemic toxicities, including non-specific effects and drug resistance, while also facing limited bioaccessibility to cancer tissues.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What does the review focus on regarding smart cancer delivery vehicles?",{"text":117,"@type":113},"It summarizes multiple types of smart therapeutic carriers and explains their drug-delivery mechanisms, emphasizing advantages for cancer treatment and roles in immunotherapy.",{"name":119,"@type":110,"acceptedAnswer":120},"How do smart delivery vehicles support cancer therapy beyond drug delivery alone?",{"text":121,"@type":113},"They can enhance tumor targeting and stability, enable monitoring of tumor-related biomarkers for early diagnosis, and improve therapeutic outcomes when combined with other emerging strategies.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343144,1790557165,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Nanoscale Advances  \nREVIEW  \nCite this: Nanoscale Adv., 2024, 6, 4275  \nReceived 4th April 2024  \nAccepted 19th June 2024 DOI: 10.1039/d4na00285g[rsc.li/nanoscale-advances](rsc.li/nanoscale-advances)  \nSmart delivery vehicles for cancer: categories, unique roles and therapeutic strategies  \nYiyu Zeng,†a Yijun Gao,†a Liming He,b Wenhui Ge,a Xinying Wang,a Tao Maa and Xiaoyan Xie  *a  \nChemotherapy and surgery remain the primary treatment modalities for cancers; however, these techniques have drawbacks, such as cancer recurrence and toxic side eﬀects, necessitating moreeﬃcient cancer treatment strategies. Recent advancements in research and medical technology have provided novel insights and expanded our understanding of cancer development; consequently, scholars have investigated several delivery vehicles for cancer therapy to improve the eﬃciency of cancer treatment and patient outcomes. Herein, we summarize several types of smart therapeutic carriers and elaborate on the mechanism underlying drug delivery. We reveal the advantages of smart therapeutic carriers for cancer treatment, focus on their eﬀectiveness in cancer immunotherapy, and discuss the application of smart cancer therapy vehicles in combination with other emerging therapeutic strategies for cancer treatment. Finally, we summarize the bottlenecks encountered in the development of smart cancer therapeutic vehicles and suggest directions for future research. This review will promote progress in smart cancer therapy and facilitate related research.  \n1. Introduction  \nCancer is the leading cause of mortality worldwide.1 The World Health Organization estimated that the number of cancerrelated deaths will increase by 2030 .2 Therefore, eﬀective treatment of cancers remains urgently needed.  \nSurgery, radiotherapy, and chemotherapy are the 􀀁rst-line treatment options for most cancers.3 Conventional chemotherapy, a fundamental approach to cancer treatment, distributes drugs through the bloodstream to various organs, where it interferes with DNA synthesis and mitosis in rapidly proliferating cells and causes cell-cycle arrest.4,5 However, chemotherapy is associated with multidrug resistance (MDR), nonspeci􀀁c drug distribution, and systemic toxicities.6 Chemotherapeutic drugs are non-selective; their cytotoxic eﬀects can damage healthy tissue cells, leading to adverse toxic eﬀects, such as cardiotoxicity in the case of adriamycin7 or hepatotoxicity in the case of camptothecin.8 In addition, conventional chemotherapeutic drugs are less bioaccessible to cancer tissues; therefore, high dosages are required, which in turn produces toxicity in normal cells and increases the likelihood of multi-drug resistance.9 The eﬃcacy of cancer therapy is in􀀃uenced by drug tolerance, eﬀective drug delivery, and  \naDepartment of Stomatology, The Second Xiangya Hospital, Central South University,  \nChangsha, 410011, [P. R. China. E-mail: xyxie@csu.edu.cn](P. R. China. E-mail: xyxie@csu.edu.cn)  \nbDepartment of Stomatology, Changsha Stomatological Hospital, Changsha, 410004, P. R. China  \n† These authors contributed to the work equally.  \nduration of drug action, among others, which considerably restrict its application.10 Consequently, conventional cancer treatments are associated with disadvantages, such as diﬃculty in achieving treatment, cancer recurrence, and side eﬀects.11 Despite considerable advances in cancer treatment, cancer-related morbidity and mortality rates continue to increase.12 According to statistics, the age-standardized cancer incidence rate is 201.7/100 000 in China, 319.2/100 000 in the United Kingdom, and 352.2/100 000 in the United States. At the same time, the cancer mortality rate is 130.1 per 100 000 in China, 102.6 per 100 000 in the United Kingdom, and 91.0 per 100 000 in the United States.13 Therefore, highly eﬀective and less toxic strategies that can diﬀerentiate between cancer and normal cells, selectively target cancer tissue, and respond“intelligently” to","cbCaigLKCAWs60kN","https://ap.wps.com/l/cbCaigLKCAWs60kN","pdf",2690232,34,"English","# Introduction\n# Smart therapeutic carriers and drug-delivery mechanisms\n# Roles in cancer immunotherapy and diagnosis\n# Combination with emerging therapeutic strategies\n# Development bottlenecks and future directions","[{\"question\":\"Why are conventional chemotherapy and surgery insufficient for cancer treatment?\",\"answer\":\"They can lead to recurrence and systemic toxicities, including non-specific effects and drug resistance, while also facing limited bioaccessibility to cancer tissues.\"},{\"question\":\"What does the review focus on regarding smart cancer delivery vehicles?\",\"answer\":\"It summarizes multiple types of smart therapeutic carriers and explains their drug-delivery mechanisms, emphasizing advantages for cancer treatment and roles in immunotherapy.\"},{\"question\":\"How do smart delivery vehicles support cancer therapy beyond drug delivery alone?\",\"answer\":\"They can enhance tumor targeting and stability, enable monitoring of tumor-related biomarkers for early diagnosis, and improve therapeutic outcomes when combined with other emerging strategies.\"}]","Smart delivery vehicles for cancer: categories, unique roles and therapeutic strategies | PDF",1790050076,86,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4d9a62472b98116fc82097c05899f6de.webp",983,1287,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/100db75c7ecaacae1aa1cc3230b53def.webp",982,1286,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3e7cf5ddeae64d9a9d258613590e7e1a.webp",981,1284,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a78a6aae1616a706d06ec2a3c0485f0f.webp",980,1283]